Development of a Quantitative Tissue Optical Index of Breast Density

Trial Information

Development of a Quantitative Tissue Optical Index of Breast Density

The researcher wants to study pre-menopausal patients with hormonal positive breast cancer,
taking tamoxifen to reduce the risk of recurrence. Diffuse optical spectroscopic imaging can
captures breast density functional changes measured by MRI and mammography. The DOSI can
prove the underlying physiological origin of breast density variations and provide detail
functional index suitable for bedside assessment of tamoxifen therapy response.The role of
breast density can predict and establish, this information can help individual women decide
whether to start or continue tamoxifen therapy based on their own risk vs. benefit
assessment.